期刊文献+

急性脑血管病患者血浆t-PA、PAI-1活性测定及意义 被引量:5

The plasma level of t-PA、PAI-1 and P/t in the patients with acute cerebrovascular disorders
原文传递
导出
摘要 目的研究急性脑血管病(脑梗死和脑出血)患者的血浆组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制物(PAI-1)的活性变化及临床意义。方法采用酶联免疫吸附法测定67例急性脑梗死和53例脑出血患者的t-PA和PAI-1的活性,并计算P/t值,与50例正常对照组进行比较分析。结果急性脑血管病组患者急性期(7d内)血浆t-PA及PAI-1活性均升高,与正常对照组比较有显著性差异(P<0.05);脑梗死组P/t值与正常对照组比较有显著性差异(P<0.05);脑出血组P/t值与正常对照组比较无显著性差异(P>0.05)。结论脑梗死和脑出血患者急性期血浆P/t改变不同;脑梗死患者急性期P/t降低,体内处于相对纤溶亢进状态;脑出血患者P/t变化不明显,体内凝血纤溶机制相对平衡;P/t值可以更好地反映血液中的纤溶活性。 Objective To study the plasma level of t-PA.PAI-1 and P/t in the patients with acute cerebrovascular disorders. Methods The level of t-PA and PAI-1 were tested with ELISA. The level of t-PA and PAI-1 were compared among 67 cases of patients with acute cerebral infarction (CI). 53 cases of patients with cerebral hernorrhage (CH) group and 50 healthy persons (contral group). Results The concentration of plasma t-PA and PAI-1 were higher in acute cerebral infarction (CI) group and cerebral hemorrhage (CH) group than in contral group (P〈 0. 05). The P/t showed signincant difference between CI group and contral group (P〈0. 05) ; no signincant difference between CH group and contral group (P〈0. 05). Conclusion; The P/t might represent the fibriuolytic activity. The P/t was inverse proportion to the fibriuolytic activity. The relative increase of fibriuolytic activity was the feature of the patients with acute CI; and relative balance of fibriuolytic activity with acute CH.
出处 《卒中与神经疾病》 2007年第2期73-75,共3页 Stroke and Nervous Diseases
基金 福建省科技基金资助项目(NO.2001Z158)
关键词 脑血管病 脑梗死 脑出血 组织型纤溶酶原激活物 纤溶酶原激活物抑制物 血浆 Cerebrovascular disorders Cerebral infarction Cerebral hemorrhage Tissue-type plasminogen activator (t-PA) Plasminogen activator inhibitor-1 (PAI-1) Blood plasma
  • 相关文献

参考文献7

二级参考文献13

  • 1周维智,王为珍,张福麟.520例急性脑血管病住院病例分析[J].中风与神经疾病杂志,1996,13(1):29-31. 被引量:44
  • 2Luttun A,Lupu F,Storkebaum E,et al.Lack of plasminogen activator inhibitor-1 promotes growth and abnormal matrix remodeling of advanced atherosclerotic plaques in apolipoprotein Edeficient mice.Arterioscler Thromb Vasc Biol,2002,22 (3):499-505.
  • 3Padró T,Emeis JJ,Steins M,et al.Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.Thromb Vasc Biol,1997,15(5):893-902.
  • 4Chomike N,Henry M,Alessi MC,et al.Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls.Thromb Haemost,1994,72(1):44-53.
  • 5Salame MY,Samani NJ,Masood I,et al.Expression of the plasinogen activator systen in the human vascular wall.Atherosclerosis,2000,152(1):19-28.
  • 6Hjortland GO,Lillehammer T,Somme S et al.Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells.Exp Cell Res,2004,294(1):130-139.
  • 7Ploplis VA,Castellino FJ.Attenuation of neointima formation following arterial injury in PAI-1 deficient mice.Ann N Y Acad Sci,2001,936(3):466-468.
  • 8De Young MB,Tom C,Dichek DA.Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries.Circulation,2001,104(16):1972-1977.
  • 9Lijnen HR,Van Hoef B,Umans K,et al.Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1).J Thromb Haemost,2004,2(1):16-22.
  • 10De Waard V,Arkenbout EK,Carmeliet P,et al.Plasminogen activator inhibitor 1 and Thromb Vasc Biol,2002,22 (12):1978-1983.

共引文献33015

同被引文献71

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部